Multiplex staining depicts the immune infiltrate in colitis-induced colon cancer model.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 09 2019
Historique:
received: 21 06 2019
accepted: 20 08 2019
entrez: 4 9 2019
pubmed: 4 9 2019
medline: 24 10 2020
Statut: epublish

Résumé

Assessment of the host immune response pattern is of increasing importance as highly prognostic and diagnostic, in immune-related diseases and in some types of cancer. Chronic inflammation is a major hallmark in colon cancer formation, but, despite the extent of local inflammatory infiltrate has been demonstrated to be extremely informative, its evaluation is not routinely assessed due to the complexity and limitations of classical immunohistochemistry (IHC). In the last years, technological advance helped in bypassing technical limits, setting up multiplex IHC (mIHC) based on tyramide signal amplification (TSA) method and designing software suited to aid pathologists in cell scoring analysis. Several studies verified the efficacy of this method, but they were restricted to the analysis of human samples. In the era of translational medicine the use of animal models to depict human pathologies, in a more complete and complex approach, is really crucial. Nevertheless, the optimization and validation of this method to species other than human is still poor. We took advantage of Multispectral Imaging System to identify the immunoprofile of Dextran Sulphate Sodium (DSS)-treated mouse colon. We optimized a protocol to sequentially stain formalin fixed paraffin embedded murine colon samples for CD3, CD8a, CD4, and CD4R5B0 antigens. With this approach we obtained a detailed lymphocyte profile, while preserving the morphological tissue context, generally lost with techniques like gene expression profiling or flow cytometry. This study, comparing the results obtained by mIHC with immunophenotyping performed with cytofluorimetric and standard IHC methods validates the potentiality and the applicability of this innovative approach.

Identifiants

pubmed: 31477791
doi: 10.1038/s41598-019-49164-3
pii: 10.1038/s41598-019-49164-3
pmc: PMC6718623
doi:

Substances chimiques

Dextran Sulfate 9042-14-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12645

Références

Sci Rep. 2018 Jul 24;8(1):11158
pubmed: 30042403
J Immunol Methods. 2014 Mar;405:97-108
pubmed: 24508527
J Immunol. 2018 Sep 15;201(6):1605-1613
pubmed: 30181299
Cancer Res Front. 2016 Feb;2(1):1-21
pubmed: 27110580
Curr Cancer Drug Targets. 2011 May;11(4):451-64
pubmed: 21247378
Oncol Lett. 2018 Mar;15(3):3876-3882
pubmed: 29456737
Inflamm Bowel Dis. 2015 Jul;21(7):1553-63
pubmed: 25939039
J Immunol. 2016 May 1;196(9):3943-50
pubmed: 26994219
J Histochem Cytochem. 2017 Aug;65(8):431-444
pubmed: 28692376
Biomaterials. 2011 Apr;32(11):2907-17
pubmed: 21262536
Cancer Res. 2011 Sep 1;71(17):5670-7
pubmed: 21846824
J Immunol. 2019 Jan 1;202(1):292-299
pubmed: 30510069
Lab Invest. 1993 Aug;69(2):238-49
pubmed: 8350599
Clin Exp Dermatol. 2000 Jul;25(5):423-31
pubmed: 11012601
J Histochem Cytochem. 2009 Oct;57(10):899-905
pubmed: 19365090
Matrix Biol. 2019 Aug;81:34-49
pubmed: 30408617
Nat Commun. 2017 Apr 27;8:15095
pubmed: 28447602
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
Immunopharmacol Immunotoxicol. 2018 Jun;40(3):193-200
pubmed: 29433367
Cancer Biol Ther. 2018 Feb 1;19(2):105-112
pubmed: 29219668
Ann Surg Treat Res. 2014 Jun;86(6):309-13
pubmed: 24949322
J Histochem Cytochem. 2007 Jun;55(6):545-54
pubmed: 17242468
Methods. 2014 Nov;70(1):46-58
pubmed: 25242720
Immunity. 2012 Aug 24;37(2):364-76
pubmed: 22863836
J Immunol. 2018 Jan 1;200(1):347-354
pubmed: 29141863
Histopathology. 2017 Mar;70(4):643-649
pubmed: 27571246
J Biomed Opt. 2005 Jul-Aug;10(4):41207
pubmed: 16178631
J Immunol Methods. 2013 Mar 29;389(1-2):29-37
pubmed: 23279944
Sci Rep. 2015 Mar 31;5:9534
pubmed: 25826597
Mol Cell Biol. 2013 Nov;33(22):4381-94
pubmed: 24019067
Methods Mol Biol. 2016;1438:245-54
pubmed: 27150094
Int Immunol. 2016 Aug;28(8):373-82
pubmed: 27121213

Auteurs

Eliana Pivetta (E)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy. epivetta@cro.it.

Alessandra Capuano (A)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Eugenio Scanziani (E)

Department of Veterinary Medicine, University of Milan, Milan, Italy.
Mouse and Animal Pathology Lab (MAPLab), Fondazione Filarete, Milan, Italy.

Lucia Minoli (L)

Department of Veterinary Medicine, University of Milan, Milan, Italy.
Mouse and Animal Pathology Lab (MAPLab), Fondazione Filarete, Milan, Italy.

Eva Andreuzzi (E)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Maurizio Mongiat (M)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Gustavo Baldassarre (G)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Roberto Doliana (R)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Paola Spessotto (P)

Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH